Highlights from day 1 of Sequencing, Finishing and Analysis in the Future Meeting (SFAF 2014)
More highlights on our blog: http://blog.genohub.com/sequencing-f...ng-highlights/
We're also posting updates on Twitter. Checkout #SFAF2014
- Genohub
- Steve Turner from Pacbio declined to discuss or entertain discussion on benchtop platform. This was met with lots of audience laughter
- Illumina had no response for ONT except to say they’re not going to respond to ONT until after they launch…ouch.
- Pacbio said that right now read length is not being limited by on board chemistry but rather quality of input DNA.
- Roche 454 is phasing out 454 but looking to compete on 4-5 other possibilities (very interesting news)
More highlights on our blog: http://blog.genohub.com/sequencing-f...ng-highlights/
We're also posting updates on Twitter. Checkout #SFAF2014
- Genohub